- Home
- RNP vs FTH Comparison
RNP vs FTH Comparison
Compare RNP & FTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RNP | FTH |
|---|---|---|
| Founded | 2003 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Managers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 984.5M | 835.7M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | RNP | FTH |
|---|---|---|
| Price | $18.42 | $17.43 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 16 |
| Target Price | N/A | ★ $56.14 |
| AVG Volume (30 Days) | 136.8K | ★ 320.5K |
| Earning Date | 01-01-0001 | 11-13-2026 |
| Dividend Yield | ★ 7.94% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $18.01 | $17.50 |
| 52 Week High | $21.88 | $42.14 |
Technical Indicators
Market Signals| Indicator | RNP | FTH |
|---|---|---|
| Relative Strength Index (RSI) | 43.63 | 27.08 |
| Support Level | $18.01 | N/A |
| Resistance Level | $20.82 | $36.63 |
| Average True Range (ATR) | 0.28 | 2.30 |
| MACD | 0.06 | -0.30 |
| Stochastic Oscillator | 65.36 | 1.70 |
Price Performance
Historical ComparisonAbout RNP Cohen & Steers REIT and Preferred and Income Fund Inc.
Cohen & Steers REIT and Preferred Income Fund Inc is a diversified, closed-ended investment management fund. Its investment objective is to provide high current income with capital appreciation as its secondary objective. The Fund invests at least its total assets in common stocks issued by real estate investment trusts (REITs) and preferred securities under normal circumstances. The Fund seeks to achieve its objectives through a portfolio of income producing common stock issued by REITs and preferred and other debt securities.
About FTH Faeth Therapeutics Inc. Common Stock
Faeth Therapeutics Inc is a clinical-stage biotechnology company focused on improving outcomes for cancer patients through multi-node inhibition of critical oncogenic pathways. The company's principal program is PIKTOR, an investigational all-oral combination of serabelisib and sapanisertib in development for endometrial and breast cancer.